World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
13242
World Ranking
11932
National Ranking
5123

Rugang Zhang publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Rugang Zhang sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 397 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Rugang Zhang D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Rugang Zhang sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 60 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Rugang Zhang is affiliated with The Wistar Institute in the United States and has a research portfolio spanning biochemistry, genetics and molecular biology, medicine, and immunology and microbiology. Their work extensively covers molecular biology, immunology, oncology, radiology, nuclear medicine and imaging, as well as pathology and forensic medicine.

The main topics Rugang Zhang investigates include chromatin remodeling and cancer, immune cells in cancer, cancer mechanisms and therapy, RNA modifications and cancer, immunotherapy and immune responses, epigenetics and DNA methylation, and interferon and immune responses.

Recent papers by Rugang Zhang include:

  • Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models, 2020, Nature Communications
  • Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils, 2020, Science Translational Medicine
  • Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy, 2020, Journal of Clinical Investigation
  • m6A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype, 2021, Nature Cell Biology
  • EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition, 2020, Cancer Cell

Frequent co-authors with Zhang include Andrew V. Kossenkov, Hao Xue, Jianhuang Lin, Wei Zhou, and Hao Nie.

The most common venues where Rugang Zhang's research appears are:

  • Cancer Research
  • Nature Communications
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature
  • Regular and Young Investigator Award Abstracts

Best Publications

  • Formation of MacroH2A-Containing Senescence-Associated Heterochromatin Foci and Senescence Driven by ASF1a and HIRA

    Rugang Zhang;Maxim V. Poustovoitov;Maxim V. Poustovoitov;Xiaofen Ye;Hidelita A. Santos

  • Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A -mutated cancers

    Benjamin G. Bitler;Katherine M. Aird;Azat Garipov;Hua Li

  • Molecular Dissection of Formation of Senescence-Associated Heterochromatin Foci

    Rugang Zhang;Wei Chen;Peter D. Adams

  • BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression.

    Hengrui Zhu;Fee Bengsch;Nikolaos Svoronos;Melanie R. Rutkowski

  • sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

    Amanpreet Kaur;Amanpreet Kaur;Marie R. Webster;Katie Marchbank;Reeti Behera

  • Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation

    Melanie R. Rutkowski;Tom L. Stephen;Nikolaos Svoronos;Michael J. Allegrezza

  • NAD+ metabolism governs the proinflammatory senescence-associated secretome

    Timothy Nacarelli;Lena Lau;Takeshi Fukumoto;Joseph Zundell

  • Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence

    Katherine M. Aird;Gao Zhang;Hua Li;Zhigang Tu

  • Downregulation of Wnt Signaling Is a Trigger for Formation of Facultative Heterochromatin and Onset of Cell Senescence in Primary Human Cells

    Xiaofen Ye;Brad Zerlanko;Alyssa Kennedy;Gowrishankar Banumathy

  • Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA-Mutant Ovarian Cancer Models

    Hyoung Kim;Erin George;Ryan L. Ragland;Stavros Rafail

  • Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models

    Hyoung Kim;Haineng Xu;Erin George;Dorothy Hallberg

  • Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis.

    Alyssa L. Kennedy;Jennifer P. Morton;Indrani Manoharan;David M. Nelson

  • ARID1A -mutated ovarian cancers depend on HDAC6 activity

    Benjamin G. Bitler;Shuai Wu;Pyoung Hwa Park;Yang Hai

  • PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion

    M. Cecilia Caino;Jagadish C. Ghosh;Young Chan Chae;Valentina Vaira

  • Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers

    Jiao Yuan;Zhongyi Hu;Brandon A. Mahal;Sihai Dave Zhao

  • Definition of pRB- and p53-Dependent and -Independent Steps in HIRA/ASF1a-Mediated Formation of Senescence-Associated Heterochromatin Foci

    Xiaofen Ye;Brad Zerlanko;Rugang Zhang;Neeta Somaiah

  • Tumor Cell-Independent Estrogen Signaling Drives Disease Progression Through Mobilization of Myeloid-Derived Suppressor Cells

    Nikolaos Svoronos;Alfredo Perales-Puchalt;Michael J. Allegrezza;Melanie R. Rutkowski

  • Nucleotide Metabolism, Oncogene-Induced Senescence and Cancer

    Katherine M. Aird;Rugang Zhang

  • BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer

    Sergey Karakashev;Hengrui Zhu;Yuhki Yokoyama;Bo Zhao

  • Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.

    Shuyun Rao;Sang-Yun Lee;Alejandro Gutierrez;Jacqueline Perrigoue

Frequent Co-Authors

Andrew V. Kossenkov
Andrew V. Kossenkov The Wistar Institute
David W. Speicher
David W. Speicher The Wistar Institute
Peter D. Adams
Peter D. Adams Sanford Burnham Prebys Medical Discovery Institute
Jose R. Conejo-Garcia
Jose R. Conejo-Garcia Duke University
Lin Zhang
Lin Zhang University of Pennsylvania
Ronny Drapkin
Ronny Drapkin University of Pennsylvania
Meenhard Herlyn
Meenhard Herlyn The Wistar Institute
Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
Ie Ming Shih
Ie Ming Shih Johns Hopkins University
Louise C. Showe
Louise C. Showe The Wistar Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your studies in Biology and Biochemistry can lead you to a variety of rewarding career paths. Today, many top universities offer flexible online programs, allowing you to specialize further in areas connected to health, exercise, and pharmaceutical sciences.

For those interested in healthcare leadership roles, consider exploring doctoral programs for healthcare administration. These programs are ideal if you’re looking to move into hospital management or policy development.

If your interests lie in the pharmaceutical sector, pursuing online pharm d programs can prepare you for advanced positions as a licensed pharmacist or researcher.

There’s also strong demand for professionals in fitness, sports, and rehabilitation. A sports science degree online offers the knowledge needed to work with athletes, while a kinesiology online degree is excellent for careers in physical therapy or movement science.

Whatever your focus, these online degrees provide flexible study options and open the door to diverse roles across healthcare, research, and wellness industries.

Best Scientists Citing Rugang Zhang

Trending Scientists

Recently Published Articles